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Abstract: The abilities of cancer-associated fibroblasts (CAFs) to regulate immune responses in
the context of radiotherapy remain largely unknown. This study was undertaken to determine
whether ionizing radiation alters the CAF-mediated immunoregulatory effects on macrophages.
CAFs were isolated from freshly-resected non-small cell lung cancer tumors, while monocyte-derived
macrophages were prepared from peripheral blood of healthy donors. Experimental settings included
both (CAF-macrophage) co-cultures and incubations of M0 and M1-macrophages in the presence of
CAF-conditioned medium (CAF-CM). Functional assays to study macrophage polarization/activation
included the expression of cell surface markers, production of nitric oxide, secretion of inflammatory
cytokines and migratory capacity. We show that CAFs promote changes in M0-macrophages that
harmonize with both M1-and M2-phenotypes. Additionally, CAFs inhibit pro-inflammatory features
of M1-macrophages by reducing nitric oxide production, pro-inflammatory cytokines, migration,
and M1-surface markers expression. Radiation delivered as single-high dose or in fractioned regimens
did not modify the immunoregulatory features exerted by CAFs over macrophages in vitro. Protein
expression analyses of CAF supernatants showed that irradiated and non-irradiated CAFs produce
approximately the same protein levels of immunoregulators. Thus, CAF-derived soluble factors
mediate measurable changes on uncommitted macrophages and down-regulate pro-inflammatory
features of M1-polarized macrophages. Notably, ionizing radiation does not curtail the CAF-mediated
immunosuppressive effects.
Keywords: cancer-associated fibroblasts; CAFs; ionizing radiation; radiotherapy; macrophages;
immunoregulation; immunosuppression
1. Introduction
Radiotherapy (RT) is a highly efficient and widely used treatment modality for solid tumors and is
largely understood as a localized treatment modality, aiming to induce tumor cell killing while keeping
effects on the surrounding healthy tissue at a minimum. In recent years, the field of radiation oncology
is embracing the notion that RT may trigger not only local but also systemic immune-modulating
effects [1–4]. In fact, preclinical and clinical studies have shown that RT may profoundly alter
cellular and acellular components of the tumor microenvironment (TME) [5] and transform it from
immunosuppressive to immunoreactive [4–6]. Despite the well-described synergism between RT and
different forms of immunotherapies, results at the clinical front from radio-immune combinatory trials
are still modest [7–12]. There are still many overlooked variables in the studies exploring radiation
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and the immune system. A more thorough biological understanding of the effects elicited by ionizing
radiation in TME elements may aid in the design of more efficient treatment strategies.
CAFs represent a heterogeneous population of connective tissue cells that are both numerically
and functionally prominent constituents of solid neoplasms [13–15]. Numerous correlative studies
have demonstrated that a high abundance of tumor-infiltrating CAFs and high stroma/carcinoma
ratios is associated with poor prognosis and treatment outcomes [16]. Contrary to quiescent normal
tissue fibroblasts, tumor-resident fibroblasts (CAFs) contribute to cancer progression essentially
by the secretion of a long array of soluble factors, comprising cytokines, chemokines, growth
factors and proteases that on one hand regulate the behavior of adjacent tumor cells [17,18],
but also mediate recruitment of inflammatory and immune cells, including mobilization of bone
marrow-derived progenitor cells [19]. Amongst the mechanisms that tumors use to evade immune
rejection, immunosuppressive effects elicited by non-malignant TME-components play a major role.
As a major constituent of the tumor stroma, CAFs participate actively in the regulation of both
innate and adaptive anti-tumor immune responses [20]. In fact, through the secretion of a plethora of
immunoregulatory signals, stromal fibroblasts are efficient regulators of the local immunity in tumors,
with the capacity to directly affect trafficking, state of differentiation and activation of a broad population
of immune cells. Among some observed effects, CAFs may influence T-regulatory cells recruitment and
functionality by the production of prostaglandin E2 (PGE2) and can impair Th1 differentiation, cytotoxic
T lymphocytes (CTL) activation or dendritic cells (DCs) maturation by secretion of transforming
growth factor-beta (TGF-β) or the immunoregulatory enzyme indoleamine-2,3-dioxygenase (IDO) [21].
Moreover, some recent reports highlight indirect effects mediated by CAFs on immune cell infiltration
and function, consisting of regulation of angiogenesis, lymph-angiogenesis, hypoxia, extracellular
matrix remodeling and metabolism [22].
In particular, CAFs may play important roles in the regulation of macrophage recruitment,
polarization and functions [23]. Macrophages are broadly classified into two distinct categories:
the M1-like or classically activated type and the M2-like or alternatively activated type [24].
M1-macrophages exhibit a pro-inflammatory phenotype characterized by the production of
different proinflammatory cytokines and reactive oxygen and nitrogen species and have the
capacity to orchestrate Th1 anti-tumor immune responses. In contrast, M2-macrophages orchestrate
a tumor-promoting tissue-repair response characterized by the secretion of pro-angiogenic and
immunosuppressive factors such as IL-10, IDO, VEGF, TGF-β and Arginase, which inhibit cytotoxic
CD8+ T-cell mediated immune attack [25]. However, the use of the terms M1 and M2 remains
controversial due to lack of tightly defined criteria to score phenotypes [24]. Macrophages display
great plasticity and can adopt different activation states within many possibilities. In some
settings, CAFs actively promote the migration of monocytes to the TME and their differentiation
towards M2-macrophages [26]. Particularly, the secretion of IL-6, CCL2/MCP-1, M-CSF/CSF-1 or
SDF-1/CXCL12 by CAFs have been shown to promote migration, cell survival and M2-polarization of
monocytes/macrophages [27–29].
Ionizing radiation (IR) in a clinical setting affects not only the malignant cells but also all the
non-malignant components present in the TME, thus provoking also tumor cell-extrinsic responses
to treatment [5,6]. Hence, as a major constituent of the tumor mass, CAFs receive the prescribed
radiation dose in full during external beam RT treatment, and the downstream biological effects
may depend on radiation dose and fractionation. Evidence from in vitro studies indicates that CAF
is a very radioresistant cell type and may survive to even ablative doses of ionizing radiation [30].
However, radiation doses above 12 Gy induce permanent DNA damage responses and the concomitant
development of irreversible cellular senescence. Additionally, high radiation doses are able to influence
the secretory profile of CAFs, thus affecting potential CAF-mediated paracrine signaling [18]. In this
study, we explore if CAF-mediated immunoregulatory effects on macrophages are changed after
exposure of CAF cultures to different radiation regimens.
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2. Results
2.1. Isolation of CAFs, Irradiation, and Macrophage Polarization
CAFs were isolated from non-small cell lung cancer tissue by enzymatic digestion and outgrowth,
as described by Hellevik et al. [30]. Under the light microscope, CAFs appeared elongated with
spindle-shaped morphology, as illustrated in Figure 1A. Fibroblasts expanded in monolayers were
checked for lineage-specific markers including alpha-smooth muscle actin (α-SMA) and fibroblast
activation protein (FAP-1) [30]. In this study, CAFs were collected from five different donors to
complete all the experimentation. Figure 1A illustrates that irradiated cells acquired a flat and enlarged
morphology, indicative of prematurely induced cellular senescence and growth arrest. The extent
of cell senescence in CAFs was demonstrated by β-galactosidase staining five days after the first
radiation dose (Figure 1B). Irradiated cultures showed prominent induction of β-galactosidase staining,
suggesting that large numbers of irradiated CAFs entered growth arrest by activating premature cellular
senescence mechanisms. The senescence response was more pronounced after a single-high dose (62%)
than after fractionated radiation regimens (37%) (Figure 1C). Of note, no cell death was observed after
any of the radiation regimens over a 3 weeks period, as assessed by light microscopy (rounded and/or
floating cells). Aspects of CAF-viability post-IR have been reported previously by us [31].
Cancers 2019, 11, x 3 of 18 
 
2. Results 
2.1. Isolation of CAFs, Irradiation, and Macrophage Polarization  
CAFs were isolated from non-small cell lung cancer tissue by enzymatic digestion and 
outgrowth, as described by Hellevik et al. [30]. Under the light microscope, CAFs appeared elongated 
with spindle-shaped morphology, as illustrated in Figure 1A. Fibroblasts expanded in monolayers 
were checked for line ge-specific markers including alpha-smooth muscle actin (α-SMA) and 
fibroblast activation protein (FAP-1) [30]. In this study, CAFs were collected from five different 
donors to complete all the experi entation. Figure 1A illustrates that irradiated cells acquired a flat 
and nlarged morphology, indicative of prematurely induced cellular senescence and growth arres . 
The extent of cell senescence in CAFs was demonstrated by β-galactosidase staining five days after 
the first radiation dose (Figure 1B). Irradiated cultures showed prominent induction of β-
galactosidase staining, suggesting that large numbers of irradiated CAFs entered growth arrest by 
activating premature cellular senescence mechanisms. The senescence response was more 
pronounced after a single-high dose (62%) than after fractionated radiation regimens (37%) (Figure 
1C). Of note, no cell death was observed after any of the radiation regimens over a 3 weeks period, 
as assessed by light microscopy (rounded and/or floating cells). Aspects of CAF-viability post-IR have 
been reported previously by us [31] 
Figure 1D shows a representative image of adherent macrophages in co-culture with fibroblasts. 
Attached fibroblasts exhibited a significantly higher degree of elongation compared with 
macrophages. M0-macrophages appeared elongated in shape and firmly attached to the surface as 
compared to the round morphology showed by purified blood (CD14+) monocytes (Figure 1E). 
Addition of LPS and IFN-γ, which stimulate M1 polarization, caused cells to flatten into a round-like 
shape within 48 h of stimulation. 
 
Figure 1. (A) Cancer-associated fibroblasts (CAF) cultures and senescence induction by ionizing
radiation. Culture-expanded human lung tumor CAFs were divided into three groups and irradiated
with a clinical linear accelerator. One group was irradiated once with high-dose radiation (1 × 18 Gy)
and another with three daily doses of 6 Gy. (B) Radiation-induced senescence was demonstrated by
a β-galactosidase assay, where β-gal positive cells develop blue color. (C) Percentage of β-galactosidase
positive cells in each condition was calculated from two different donors. Student’s t-test and p-values
were determined between the two iCAF-groups. (D) Photomicrograph showing CAFs and macrophages
in co-culture. (E) Macrophage isolation and polarization: Monocytes (CD14+) were isolated from PBMCs
and incubated with M-CSF to induce macrophage differentiation (M0-phenotype). Monocyte-derived
M0-macrophages were further polarized into M1-macrophages by LPS and IFN-γ. Scale Bars = 15 µm.
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Figure 1D shows a representative image of adherent macrophages in co-culture with fibroblasts.
Attached fibroblasts exhibited a significantly higher degree of elongation compared with macrophages.
M0-macrophages appeared elongated in shape and firmly attached to the surface as compared to the
round morphology showed by purified blood (CD14+) monocytes (Figure 1E). Addition of LPS and
IFN-γ, which stimulate M1 polarization, caused cells to flatten into a round-like shape within 48 h
of stimulation.
2.2. CAF-Mediated Effects on Macrophage Polarization
To investigate the effects of ionizing radiation on CAF-mediated regulation of macrophage
polarization, we exposed unstimulated (M0) or M1-macrophages with CM from irradiated or
non-irradiated CAFs or in co-cultures. Thereafter, we analyzed the expression of specific type-1
and type-2 macrophage surface markers by flow cytometry. Considering the potentially different
effects triggered by different radiation schemes, we compared the effects of fractioned radiation vs
single-high dose radiation on CAFs-mediated macrophage polarization. Results presented in Figure 2,
represent average determinations from five different CAFs donors. Figure 2 shows the relative surface
expression of M1-macrophage co-stimulatory molecules CD80, CD86, and CD40, as determined by flow
cytometry. It is evident that CD80 was significantly enhanced in uncommitted M0-macrophages by all
CAF-CMs, but unchanged in stimulated (M1) macrophages (top panel). Neither irradiated (iCAF-CM)
nor non-irradiated CAF-CM was able to alter the expression of CD86 in resting (M0) or stimulated
(M1)-conditions (middle panel). On the other hand, expression of CD40 was moderately increased
by all CAF-CM in M0-macrophages, but was statistically significant (p ≤ 0.05) only for the irradiated
(CAF-CM) conditions. No effects were observed for CD40 expression in M1-stimulated conditions
(lower panel). In co-cultures, CAFs were able to induce a slight increase of CD80 but had no effects
on the expression of CD86 or CD40 in M0-macrophages, except for the fractionated irradiated CAF
group (fiCAFs), which demonstrated slightly elevated expression of co-stimulatory CD40 (Figure 2).
Otherwise, no relevant differences were observed on M1-macrophage marker regulation after exposure
to irradiated or non-irradiated CAFs. CAFs grown in co-cultures with M1-macrophages induced
a slight decrease of CD80 expression and a significant decrease of CD40 expression, but unaltered
effects on CD86 expression. Results were statistically significant (p = 0.011) for the fiCAF group
regarding CD40 expression levels. Of note, we did not observe statistically significant differences in
the expression of any of the receptors in any of the experimental settings when comparing irradiated
with non-irradiated CAF conditions both in co-cultures or CM.
In Figure 3, the relative surface expression of the classical M2-macrophage surface markers
mannose receptor (CD206) and scavenger receptor (CD163) is illustrated. In non-stimulated conditions
(M0), incubation with iCAF-CM or CAF-CM increased the expression of CD206. On the contrary,
in stimulated (M1) conditions, the two irradiated CAF-CMs slightly decreased the expression of
CD206. Surface expression of CD163 on M0-macrophages increased to some extent after exposure to
iCAF-CM and fiCAF-CM, although differences were not significant. Similarly, in M0-macrophages,
both irradiated CAF-CMs slightly increased the expression of CD163. No statistical differences were
observed between the irradiated and non-irradiated CAF-CM effects on CD163 and CD206 expression
on M1-macrophages. In co-cultures consisting of (non-irradiated) CAFs and M0-macrophages, CAFs
induced a noticeable enhancement in the expression of M2-markers CD206 and CD163 in the (M0)
macrophages. However, this effect was to some extent blocked after co-culturing (M0-) macrophages
with fiCAFs or iCAFs. On the other hand, in co-cultures with M1-macrophages and CAFs/iCAFs/fiCAFs,
enhanced expression of CD206 was observed from CAFs and iCAFs, whereas enhanced expression of
CD163 was only observed from fiCAFs. Nevertheless, differences from controls in these co-cultures
were not statistically significant, due to prominent inter-donor heterogeneity.
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Figure 2. Effects of CAFs on M1-macrophage cell surface markers. Monocyte-derived macrophages in
non-stimulated or stimulated conditions were incubated with conditioned medium from irradiated
(iCAF-CM) or non-irradiated CAFs (CAF-CM) or in (macrophage-CAF) co-cultures (CC). Resulting
surface expression of M1-macrophage cell surface markers CD80, CD86 and CD40 were evaluated by
flow cytometry. Filled black circles indicate surfac levels in control macrophage cultures (M0 and M1).
Results are expressed as fold M0-controls. Data represent mean (±SD) values from four-4 different CAF
donors measured independently. Non-parametric Kruskal-Wallis test and p-values were determined
between control and non-irradiated CAFs, control and the two iCAF-groups individually. iCAF
(irradiated CAFs); fiCAFs: fractionated-irradiated CAFs.
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in non-stimulate or stimula ed conditions were incubated with irradi ted and n -irradiat d
CAF-conditioned medium (CM) or in co-cultures (CC). Resulting expression of M2-macrophage cell surface
markers CD206 and CD163 was evaluated by flow cytometry. Filled black circles indicate expression
levels in control macrophage cultures (M0 and M1). Results are expressed as fold M0-controls.
Data represent the mean (±SD) values from four-4 different CAF donors in conditioned medium
experiments and three donors in co-culture experiments were measured independently. Non-parametric
Kruskal-Wallis test and p-values were determined between control and non-irradiated CAFs, control
and the two iCAF-groups individually. iCAF (irradiated CAFs); fiCAFs: fractionated-irradiated CAFs.
2.3. Effects of CAFs on Macrophage Cytokine Secretion
To further explore the immunoregulatory properties exerted by CAFs, we checked the capacity
of CAFs to modulate cytokine secretion by macrophages. To this end, we examined macrophage
cytokine production resultin from exposure to CAF-CM or during co-cultures. In Figure 4, results
from corresponding analyses of IL-6, TNF-α, IL-10, and IL-12 from uncommitted (M0) and stimulated
M1-macrophages is presented. When M0-macrophages were incubated with CAF-CM, all CMs were
able to increase, to a certain degree, IL-6 production (Figure 4, top-left panel), reaching statistical
significance with the fractioned radiation group (fiCAF-CM) (p = 0.014). On the contrary, in the
stimulated M1-condition, IL-6 production was unchanged up n exposure to irradiated (CAF-CM)
and significantly reduced by CAF-C . Interestingly, in co-culture conditions at included either M0-
or M1-m crophages, IL-6 was significantly elevated i M0-macrophages (CAFs p = 0.035 and iCAFS
p = 0.017) and (or near-significantly) in M1 macrophages from baseline levels by both CAFs and the
two iCAFs (Figure 4, top-right panel).
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conditioned medium (CM) or in (CAF-macrophage) co-cultures (CC). Resulting levels of cytokines
secreted by macrophages were quantified by ELISA assay. Data represent the mean (±SD) values
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Secreted levels of IL-12 and TNF-α by M0-macrophages was negligible and unchanged in all
experimental conditions (Figure 4, middle panels). For M1-macrophages, both iCAF-CM and CAF-CM
(p = 0.045) resulted in decreased production of IL-12 and reduced TNF-α to some extent. In co-culture
conditions, CAFs and iCAFs reduced M1-macrophage secretion of TNF-α and IL-12 (CAFs p = 0.093
and iCAFs p = 0.068).
Interleukin (IL)-10 is a recognized marker for M2-macrophages [23,32] and expected to be induced
under IL-4 and TGF-β stimulation. However, unexpectedly, the production of IL-10 was highest in
M1-conditions. Previous studies have also reported similar observations with IL-10 [33]. Conditioned
medium from all CAF experimental groups had the capacity to trigger induction of IL-10 secretion
by M0-macrophages, and was significantly increased from CAF-CM and iCAF-CM (p = 0.035 and
p = 0.017, respectively) compared to baseline levels (Figure 4, bottom-left panel). IL-10 induction was
less prominent with the fiCAF group. On the other hand, exposure of M1-macrophages to iCAF-CM or
CAF-CM resulted in reduced secretion of IL-10, with significant reduction upon exposure to fiCAF-CM
(p = 0.040). Moreover, the CAF-mediated inhibitory effect on IL-10 secretion from M1-macrophages
was even more pronounced in co-culture conditions (Figure 4, bottom-right panel).
2.4. Effects of CAFs on Macrophage Nitric Oxide Production
Nitric oxide (NO) production is considered a hallmark of macrophage polarization and
activation [34]. Therefore, we pursued to measure immunomodulatory effects mediated by CAFs
on macrophage nitric oxide production. In Figure 5, monocyte-derived M0- or M1-macrophages
were seeded together with CAF-CM or CAFs and incubated for 48 h. Thereafter, NO assay was
performed using the membrane permeable fluorescent probe DAF-2DA. Conditioned media from all
CAF experimental groups did not change the NO-production by uncommitted (M0) macrophages
(Figure 5). On the other hand, in M1-macrophages, CAF-CM, iCAF-CM and fiCAF-CM provoked
significant reduction in NO production (p = 0.036). However, no differences were observed between
CM from irradiated vs non-irradiated CAFs. In co-cultures, both irradiated and non-irradiated CAFs
could enhance NO production by M0-macrophages. In contrast, NO production by M1-macrophages
was inhibited by all CAF-groups, with significant values only from iCAF (p = 0.037).
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2.5. CAF-Mediated Effects on Macrophage Migratory Capacity 
We next sought to explore the capacity of CAFs to modulate the migratory behavior of 
macrophages. As expected, uncommitted M0-macrophages did not migrate towards CCL19 [35]. 
Figure 5. CAF-induced nitric oxide production by macrophages. Monocyte-derived macrophages
in non-stimulated or stimulated conditions were incubated with irradiated or non-irradiated
CAF-conditioned medium (CM) or in co-culture (CC), followed by analysis of expression levels of nitric
oxide by macrophages, measured by DAF-2DA fluorescence assay. Black filled circles indicate expression
levels in control macrophage cultures (M0 and M1). Results are expressed as fold M0-controls. Data
represent the mean (±SD) values from 3 different CAF donors measured independently. Non-parametric
Kruskal-Wallis test and p-values were determined between control and non-irradiated CAFs, control
and (fractionated) irradiated CAFs individually.
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2.5. CAF-Mediated Effects on Macrophage Migratory Capacity
We next sought to explore the capacity of CAFs to modulate the migratory behavior of macrophages.
As expected, uncommitted M0-macrophages did not migrate towards CCL19 [35]. However,
as illustrated in Figure 6, M1-macrophages exposed to any of the three different CAF-CMs resulted in
reduced migratory capacity, with significant values from CAF-CM and or iCAF-CM) (p = 0.015 and
p = 0.003, respectively).
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Figure 6. CAF-mediated effects on macrophage migration. For the Transwell migration assays,
stimulated acrophages were initially incubated (48 h) with CM from irradiated or non-irr diated
CAFs befo e seeding onto the nsert membr n . The migration index was determined by c unting
transmigrated cells towards CCL19, which was added to the lower chamber. Non-parametric
Kruskal-Wallis test and p-values were determined between control and non-irradiated CAF-CM,
control and the two groups of iCAF-CM. Error bars indicate ± SD of five different CAF donors from
triplicate determinations.
2.6. Effects of Radiation on Secretion of CAF-Derived Inflammatory Mediators
CAFs are believed to exert most of their tumor-promoting functions through the secretion of
bioactive molecules into th TME, and some of these actors exert demonstrated effects on macrophage
polarization and functions [26,28,29]. In this regard, we have explored the impact of radiation on CAFs
secretory capacity. A panel of cytokines and chemokines known to regulate macrophage chemotaxis
and functions were compared between CAFs/iCAFs/fiCAFs. As is evident from Figure 7, our results
s owed n significant differences between the CAF-groups regarding cytokine secretion, as determined
from our cytokine panel consisting of IL-8, IL-10, VEGF-A, M-CSF, IL-4, TGF-β, CHI3L-YKL-40,
CXCL12/SDF-α, IL-6, and CCL2-MCP1. Of note, levels of IL-10 in the conditioned medium from both
control and irradiated CAFs were nearly undetectable.
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3. Discussion
Ionizing radiation leads to significant changes in the tumor stroma, triggering reactions such as
acute inflammation, vasculature damage, tumor tissue hypoxia, and fibrosis [5,6,36]. Those changes
result in sustained production of cytokines and chemokines that in turn can induce immune cell
recruitment and may trigger antitumor immune responses [37]. An array of studies have demonstrated
that CAFs and tumor-associated macrophages (TAMs), which together constitute the most abundant
non-cancerous cells in the tumor stroma, are synergistically related to cancer progression and
prognosis of patients [26,38–40]. However, little is known about how radiotherapy is influencing
the capacity of CAFs to modulate macrophage polarization in the tumor microenvironment. In the
present study, we have investigated (a) how CAFs may affect macrophage polarization and function
in vitro; and (b) how ionizing radiation is affecting the immunoregulatory functions exerted by
CAFs. Thereafter, we have observed that: (i) CAFs, both in co-culture and by conditioned medium,
promote changes on uncommitted macrophages (M0) that harmonize with induction of both M1- and
M2-macrophage phenotypes; (ii) CAFs, both in co-culture and by conditioned medium, inhibit some
of the pro-inflammatory features of M1-macrophages; and (iii) neither high-dose radiation (1 × 18 Gy)
nor medium-high-fractioned radiation (3 × 6 Gy) is affecting considerably the immunoregulatory
features exerted by CAFs over macrophages in vitro.
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Accumulating research have demonstrated that CAFs play an important role in macrophage
infiltration and polarization in different tumors [26,40–42]. Recent findings have shown a correlation
between CAF abundance and pro-tumoral macrophages infiltration in tumor specimens of patients
with colon cancer [39], triple negative breast cancer [41], and oral squamous cell carcinoma (OSCC) [38].
In vitro studies, based on CAFs from various tumor types, support the concept that CAFs preferentially
induce the transformation of M0-macrophages into a tumor-promoting (M2) phenotype [26,28,41].
Monocytes co-cultured with CAFs from pancreatic ductal adenocarcinoma have been shown to present
with increased surface expression of specific M2-markers, e.g., CD163, CD200R, and CD206 surface
receptors and up-regulation of ARG1, IL10, and TGFB1 genes [28]. Monocytes grown in co-cultures
with OSCC-CAFs have been shown to display increased reactive oxygen species [26]. Of note,
Zhang et al. [26] demonstrated that neutralizing antibodies to M-CSF could inhibit ROS-production
and M2-polarization of CAF-CM stimulated monocytes. Comito et al. [40] used an in vitro model of
prostate cancer and found that CAFs apparently synergize with M2-macrophages to increase cancer
cell motility and induce endothelial cells activation and a pro-angiogenic state [40]. Additionally,
in a colorectal cancer model, it has been described that CAFs can affect tumor infiltration of inflammatory
cells by promoting upregulation of cell adhesion molecules such as VCAM-1 in cancer cells [42]. In this
latter model, CAF-derived IL-8 presumably accounted for monocyte recruitment and M2 polarization.
In line with previous studies, in our study, we have observed a potent inhibition of M1-signatures on
stimulated macrophages exposed to CAFs or CAF-conditioned medium. Moreover, CAFs, irradiated
or not, also inhibit the migratory capacity of stimulated M1-macrophages in vitro. On the other
hand, unstimulated M0-macrophages, co-cultured with CAFs or CAF-conditioned medium, acquired
a heterogenic phenotype with mixed M1-M2 characteristics. Takahashi et al. [28] described similar
findings regarding the expression levels of M2-markers and co-stimulatory molecules in monocytes
co-cultured with CAFs. Fully polarized M1- and M2-macrophages are only the extremes of a continuum
of functional states that cannot easily be binned into an M1 or M2 phenotype [24]. Our results thus
suggest that CAF-educated macrophages express a broader transcriptional polarized repertoire that
harmonizes with both M1 and M2 phenotypes.
It is now widely acknowledged that CAFs represents a heterogeneous population of mesenchymal
cells that can differ among tumor type, tumor stage and tumor location in the body [43]. The pleiotropic
nature of CAFs can associate with both pro-inflammatory and anti-inflammatory gene signatures
and the secretion of soluble signal mediators, e.g., TNF-α, IFN-γ, TGF-β, PGE2, IDO, CXCL-12/SDF1,
CCL2/MCP-1, Tenascin-C, IL-6, IL-4, CXCL8 [17], and nitric oxide [44], that potentially affect
macrophage polarization in different ways at different stages of cancer progression [44]. Collectively,
our results propose that CAFs promote changes in the phenotype of uncommitted macrophages,
inducing both M1- and M2-type characteristics. We have also confirmed that CAFs have a role in
redirecting M1-macrophages to an M2-phenotype, as indicated by strong inhibition of pro-inflammatory
cytokines secretion, nitric oxide production, and migration capacity.
Furthermore, we assessed the effect of fractioned versus single high-dose radiation on
CAF-mediated macrophage polarization. Previous studies, by us and others, have presented CAFs
as a highly radioresistant cell type that can sustain ablative radiation doses [30,45]. However, CAFs
exposed to a single high-dose of 12 Gy (and above) develop significant morphological changes
associated with premature cellular senescence, and an altered phenotype accompanied by functional
traits as reduced proliferation, migration, and invasion rates [30]. Importantly, irradiated CAFs
have also been shown to display increased pro-tumorigenic effects in both in vitro and in vivo
models [46–48]. Although radiotherapy induces profound phenotypic and secretory changes on CAFs,
a previous study from our group suggests that neither high-dose nor low-dose RT affect CAF-mediated
immunosuppressive functions over lymphocytes in vitro [49]. Likewise, experimental in vivo studies
have shown comparable amounts of tumor-infiltrated macrophages in mice subcutaneously inoculated
with mixed tumor cells and irradiated or non-irradiated CAFs [31].
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In the study presented here, the two radiation schemes induced morphological changes on CAFs,
but with an increased rate of senescence in CAF cultures submitted to a higher radiation dose. However,
none of the two radiation regimens were able to modify markedly the regulatory functions of CAFs
over macrophages. In agreement with this observation, radiation did not affect the release of relevant
soluble immunomodulators by CAFs.
Macrophage phenotype and recruitment can also be directly affected by radiation. Recent studies
have shown that fractionated medium-doses, between 2 and 5 Gy, is able to reprogram macrophages
from M2- to the pro-immunogenic M1-phenotype in vitro and in vivo [50,51]. In addition, high-dose
radiation of 10 Gy or higher induces the release of damage-associated molecule patterns (DAMPs),
such as high mobility group box 1 (HMGB1), by apoptotic and necrotic cells and induces the recruitment
of CD11b+ myeloid cells in the TME and reprogramming macrophages towards the tumor-promoting
M2-phenotype [52–54]. According to the presented data, regardless of the radiation scheme, RT-induced
senescent CAFs may still participate in the recruitment of myeloid and other immune suppressor
cells. Moreover, such senescent CAFs may promote the transformation of macrophages towards
a tumor-favoring phenotype. In our study, we have not tested radiation doses under 6 Gy, which in
the context of tumor macrophages could be relevant as small doses in the range of 2 Gy favor the
appearance of anti-tumoral M1 macrophages.
4. Materials and Methods
4.1. Human Material, CAF Isolation, and Cultures
Human lung CAFs were isolated from freshly resected non-small cell lung carcinoma (NSCLC)
tumor tissue from patients undergoing surgery at the University Hospital of Northern Norway
(UNN), Tromsø, as previously described [27]. Lung tumor specimens from five different patients
and blood (i.e., buffy-coats) from 10 unrelated healthy donors were used in the study, under patient
written informed consent. All methods involving human material were performed in accordance with
relevant ethical guidelines and regulations. The Regional Ethical Committee of Northern Norway
has approved the use of human material that has been included in this study (REK Nord 2014/401;
2016/714; 2016/2307).
NSCLC-derived CAFs were isolated by enzymatic digestion of tissues and the outgrowth method
and characterized by the presence of lineage-specific markers, as described previously [27]. Isolated
CAFs were cultivated in Dulbecco’s modified Eagle’s medium (DMEM) (Cat. # D6046 Sigma-Aldrich,
St Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS) (Cat. # S0115 Biochrom, Berlin,
Germany) and used for experimentation after the third and fourth passage (3–4 week-old cultures).
4.2. Irradiation of Cells
Adherent CAF cultures—cultivated in DMEM with 10% FBS and grown in T-175 flasks or in 24 well
culture plates—were irradiated when 70–90% confluent with high-energy photons, using a clinical
Varian linear accelerator, as previously described [27]. Ionizing radiation was delivered to cultured
cells either as a single-high dose (1 × 18 Gy) or in fractionated schemes (3 × 6 Gy) at 24 h intervals.
Standard parameters for dose delivery was depth 30 mm, beam quality 15 MV, dose rate of 6 Gy/min
and field sizes of 20 × 20 cm.
4.3. Beta-Galactosidase Assay
Five days post-irradiation, CAF cultures (20× 105 cells/well in 6-well plates) were washed and fixed
(5–7 min) at room temperature with freshly prepared paraformaldehyde (PFA, 2%). β-galactosidase
(5-bromo-4chloro-3-indolyl-B-D-galactopyranoside) staining was performed following instructions
from the manufacturer (Cat.no CS0030, Sigma-Aldrich, St. Louise, MO, USA). Quantity of senescent
cells in each experimental group was determined by counting blue cells on minimum three randomly
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selected fields under a Nikon Eclipse TS100 model light microscope (Tokyo, Japan). Randomly selected
fields were photographed at 100×magnification, using an Idea SPOT digital camera.
4.4. CAF-Conditioned Medium
At the third passage, CAFs were seeded at a density of 4 × 105 cells per T-75 tissue culture flask
and incubated (24 h, 37 ◦C) in DMEM (with 10% FBS). After the initial cell attachment and spreading,
cultures were gently washed with PBS (37 ◦C), new incubation medium (6 mL) was added, followed by
irradiation of cultures, as previously described [27]. Culture medium from CAFs exposed to ionizing
radiation (3 × 6 Gy) was conditioned for 48 h after the last radiation dose. For the group exposed to
(1 × 18 Gy), CM has been collected between day 3 and day 5 after irradiation. Culture supernatants
were then spun down by centrifugation (2000× g, 4 ◦C, 10 min) and then filtrated (Ø = 0.45 µm) for
elimination of contaminant cell debris. The resulting conditioned medium was either used immediately
for experimental analysis or frozen at −80 ◦C for later use.
4.5. Isolation of Peripheral Blood Mononuclear Cells and Generation of Macrophages
Peripheral blood mononuclear cells (PBMCs) were isolated from human blood (i.e., buffy-coats)
using Lymphoprep-TM (StemCell Technologies, Vancouver, BC, Canada) gradient centrifugation.
From the selected (PBMC)-pool, CD14+ monocytes were isolated using magnetic CD14+ Microbeads
(Cat. no. 130-050-201; Miltenyi Biotec, Bergisch Gladbach, Germany). Purity and recovery of
CD14+ monocytes were determined by CD14-FITC antibody labeling (Cat. no. 130-113-708; Miltenyi
Biotec), whereas cell viability was determined by propidium iodide (PI) staining and subsequent flow
cytometry analysis on a BD FACSAria III (BD Biosciences, San Jose, CA, USA). For the generation of
macrophages, CD14+ monocytes were cultured in macrophage growth medium (RPMI 1640 with 10%
FBS, 1% streptomycin/penicillin and 100 ng/mL of macrophage colony-stimulating factor (M-CSF);
(Cat. no. 300-25; PrepoTech, Rocky Hill, NJ, USA) and kept in a humidified atmosphere (5% CO2, 37 ◦C),
for 6 days. The incubation medium was replaced every three days with fresh (pre-warmed) medium.
4.6. Macrophage Polarization Protocols
M1-differentiation of uncommitted macrophages (M0) were effectuated following previously
published protocols [28]. Briefly, M1-polarization was attained by incubating M0-macrophages in
medium containing a mixture of LPS (100 ng/mL) (Cat. no. L6529; Sigma Aldrich, St. Louis, MO, USA)
and IFN-γ (20 ng/mL) for 48 h at 37 ◦C (Cat. no. 300-02; PrepoTech-USA). After 48 h of incubation with
stimulants, M1- and M2-macrophages were phenotypically characterized through surface markers
expression, nitric oxide production and the release of various inflammatory cytokines.
4.7. Cell Co-Culturing and Macrophage Stimulation by CAF-Conditioned Medium
In co-culture experiments, irradiated and non-irradiated CAF cultures were established in 24-well
plates (2× 105 cells per well). M0-macrophages were thereafter added at a density of 4 × 105 live cells per
well (Macrophages/CAFs ratio; 2:1). These cultures, with mixed cell types, were further incubated for 48 h
at 37 ◦C in macrophage growth medium (RPMI 1640 with 10% FBS, 1% streptomycin/penicillin). Similar
procedures were carried out for experiments with CAF-CMs, but instead of cells (CAFs), CAF-CM
was diluted (1:1) with fresh pre-warmed macrophage growth medium and added to the macrophage
cultures. In M1-macrophage conditions, immediately after initiation of co-culture (macrophages and
CAFs cells) or macrophages cultured with CAF-CM, cells were exposed to LPS (100 ng/mL) and IFN-γ
(20 ng/mL). Following (cellular co-culturing or CAF-CM) incubations, macrophages were harvested
and used for further analysis.
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4.8. Macrophage Cell Surface Markers by Flow Cytometry
The expression of surface markers on macrophages was analyzed by flow cytometry on BD
FACSAria III using the FlowJo software, Ver.7.2.4 (Tree Star, Ashland, OR, USA). Briefly, macrophage
preparations (2.5 × 105 cells/condition) were labeled with various fluorescent antibodies specific for
each phenotype (Miltenyi Biotec, Bergisch Gladbach, Germany). Hence, M1-phenotype markers
consisted of CD40, CD80, CD86 (Cat. no. 130-099-385, 130-110-371 and 130-113-571, respectively)
whereas M2-phenotype was identified by the markers CD206 (mannose receptor) and CD163
(Cat. No. 130-095-131 and130-099-969, respectively). Isotype controls consisted of mouse IgG1
(Cat. no. 130-098-845), REA control (Cat. no. 130-104-612) and mouse IgG2a (Cat. no. 555574;
BD Biosciences-USA). In co-culture experiments, the macrophage population was gated based on the
surface expression of CD45 proteins (Cat. no. 130-110-635).
4.9. Macrophage Nitric Oxide Production
Intracellular production of nitric oxide in macrophages was analyzed by using a cell-permeable
diacetate derivative of 4,5-Diaminofluorescein (DAF-2 DA; Cat. no. 251506; Merck Sharp and Dohme,
Kenilworth, NJ, USA). DAF-2-DA dissolved in RPMI (without phenol red; Cat. no. 11835-030;
ThermoFisher Scientific, Waltham, MA, USA) penetrates plasma membranes rapidly (at 37 ◦C) and is
hydrolyzed in the cytosol by intracellular esterase activity to DAF-2, which in turn reacts with NO
(produced by NOS) to form a soluble fluorescent triazolofluorescein. Briefly, 1 × 106 macrophages were
incubated with DAF-2DA (10 µM) in RPMI (without phenol red) for 30 min, at 37 ◦C. After removing
the DAF-2DA-containing medium, cells were washed (3×) with cold PBS and analyzed on a FACSAria
III flow cytometer. The fluorescent product was measured using excitation wavelength 450−495 nm
and emission wavelength 505–550 nm. A total of 30,000 events were saved and analyzed using the
FlowJo software, Ver.7.2.4 (Tree Star, Ashland, OR, USA). Changes in fluorescence intensity (MFI) were
calculated by subtracting intensity numbers by unstained cells from stained cells.
4.10. Macrophage Migration
CCR7-dependent migration of M1-macrophages towards CCL19 was measured using a Boyden
chamber assay. Briefly, 200µL of M1-macrophages in suspension (5× 105 cells/mL), previously incubated
with CAF-CM during 48 h (as described above), was added to the top chamber of Transwell culture
inserts (Ø = 6.5 mm, pore size 8 µm, Cat. # CLS3464, Sigma-Aldrich, St. Louis, MO, USA). Bottom
chambers were filled with fresh standard fibroblast growth medium (600µL) or with CM from irradiated
and non-irradiated CAF cultures, in the presence or absence of CCL19 (50 ng/mL) (Cat. # 130-105-744,
Miltenyi Biotec, Bergisch Gladbach, Germany) and placed in the upper compartment of a Transwell
Plate. After incubation in a humidified atmosphere (5% CO2, 37 ◦C, 3 h), macrophages that had
migrated into the lower compartment were harvested and counted under light microscopy.
4.11. Macrophage Cytokine Secretion
Quantitative determinations of protein levels of TNF-α, IL-6, IL-10 and IL-12 (Cat. no DY240-05,
DY206-05, DY217B-05, and DY1240-05, respectively) in macrophages culture medium, were determined
using ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions.
4.12. Multiplex Protein Arrays
A panel of nine-9 specific proteins, including cytokines and chemokines, was measured in
the irradiated (1 × 18 Gy and 3 × 6 Gy) or non-irradiated CAF-CM from five different donors,
by immune-based protein arrays. A customized human cytokine Multiplex kit (Cat. no. LXSHM-09;
R&D Systems, Minneapolis, MN, USA) was used to define the concentration of four-4 different
cytokines including M-CSF, IL-4, IL-6, and IL-10; three-3 chemokines including CCL2, CXCL12, CXCL8;
one-1 growth factor i.e., VEGFA; and one-1 glycoside hydrolase i.e., CH13L1. All samples were
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analyzed in duplicates and in 1:2 or 1:4 dilutions. Quantitative protein measurements (two replicates
per factor) were performed by using the Luminex Bio-Plex 200 system (Bio-Rad, Hercules, CA, USA).
Measured protein concentrations were normalized with cell numbers at specific culture conditions and
expressed as pg/mL/106 cells.
4.13. Statistical Analysis
All statistical analyses were performed using IBM SPSS statistics version 25 (IBM, Chicago, IL, USA).
Comparison of data between the three experimental groups was analyzed using the non-parametric
Kruskal-Wallis test, and significance values were adjusted by Bonferroni correction for multiple
comparisons. The level of significance was set at p < 0.05. Results were presented in graphs, where each
donor was plotted as an individual dot in the dataset. In Multiplex protein arrays and ELISAs,
only readings above the detection limit of the assay are represented in figures. The β-galactosidase
assay was analyzed using Student’s t-test and p-values were showed in the graphic.
5. Conclusions
Taken together, our data display that CAF-derived soluble factors mediate measurable changes
on uncommitted macrophages and also down-regulate pro-inflammatory features of M1-polarized
macrophages. Notably, our results indicate that ionizing radiation does not curtail the CAF-mediated
immunosuppressive effects.
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